Overview

Safety and Efficacy of Cariprazine for Mania

Status:
Completed

Trial end date:
2011-07-01

Target enrollment:

Participant gender:

Summary

The objective of this study is to evaluate the efficacy, safety, and tolerability of cariprazine monotherapy versus placebo for the treatment of acute manic or mixed episodes associated with bipolar I disorder.

Phase:

Phase 3

Details

Lead Sponsor:

Forest Laboratories

Collaborator:

Gedeon Richter Ltd.

Treatments:

Cariprazine